Heron Therapeutics | HRTX - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
ALKERMES USD 5.53B 909M 2026-05
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amarin USD 290M 51M 2025-12
ANI Pharmaceuticals USD 1.77B 269M 2025-12
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 9.02B 4.25B 2025-12
Eisai JPY 1.31T 140.95B 2025-12
Emergent BioSolutions USD 125M 51M 2023-12
Esperion Therapeutics USD 885M 351M 2025-12
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Heron Therapeutics USD 238M 7M 2025-12
Insmed USD 37.12B 6.68B 2025-12
Merck USD 297.1B 35.84B 2026-03
Nektar Therapeutics USD 15.62B 14.76B 2026-05
Neurocrine Biosciences USD 13.34B 800M 2026-05
Pacira USD 915M 149M 2026-03
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Ultragenyx Pharmaceutical USD 2.04B 176M 2026-05
Veracyte USD 2.62B 704M 2026-05
Vertex Pharmaceuticals USD 111.03B 2.55B 2026-05